Sonendo, Inc. (OTCQX: SONX) (“Sonendo” or “Company”), a leading dental technology company and developer of the GentleWave® System, announces that the Company has entered into an Asset Purchase Agreement (“APA”) with Biolase, Inc. and certain of its subsidiaries (the “Sellers”) pursuant to which the Company agreed to acquire substantially all of the assets of the Sellers and their subsidiaries for a total purchase price of $14 million, plus the assumption of certain operating liabilities and the settlement value of certain ongoing patent litigation between Sonendo’s subsidiary PIPStek, LLC and certain of the Sellers.
Read the full article: Sonendo Executes Asset Purchase Agreement to Acquire Biolase Assets //
Source: https://www.businesswire.com/news/home/20241009742679/en/Sonendo-Executes-Asset-Purchase-Agreement-to-Acquire-Biolase-Assets